Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gloucester Pharmaceuticals acquires license to FK-228

April 19, 2004

New phase I trial for VEGF Trap

April 19, 2004

CB-300945, a novel selective alpha-FR targeted thymidylate synthase inhibitor

April 19, 2004

Novacea provides evidence for the antitumor effects of DN-101 and AQ4N

April 19, 2004

Novel androgen receptor antagonist for advanced prostate cancer therapy designed by BMS

April 19, 2004

Small molecule inhibitor of hypoxia-inducible factor-1 identified

April 19, 2004

New phosphatase inhibitors active against hepatoma cells in vitro

April 19, 2004

Myriad Genetics licenses rights to new colon cancer gene MYH

April 16, 2004

SBIR grant supports Kosan's development of next-generation Hsp90 inhibitors

April 16, 2004

KID3, a glycotope-specific IgG monoclonal antibody, inhibits colon and gastric tumor growth

April 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...